<DOC>
	<DOC>NCT00902707</DOC>
	<brief_summary>The purpose of this research study is to test the ability of Mucinex, an oral, over-the-counter, FDA approved expectorant) to stimulate the clearance of inhaled particles from the subject's lungs (called "mucociliary clearance"). The study will also monitor the metabolism of the drug by the subject's body.</brief_summary>
	<brief_title>Evaluating the Effect of MucinexÂ® 1200 mg on Mucociliary and Cough Clearance From the Human Lung</brief_title>
	<detailed_description />
	<mesh_term>Guaifenesin</mesh_term>
	<mesh_term>Phenylpropanolamine</mesh_term>
	<mesh_term>Chlorpheniramine, phenylpropanolamine drug combination</mesh_term>
	<criteria>Healthy Non smoker BMI 1929 Normal lung function Pregnant Smokers Any illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>healthy nonsmokers</keyword>
</DOC>